Skip to main content

Table 2 Course of laboratory tests over time in patient 2

From: Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases

Days from admission at Authors’ center

-4

0

+ 20

+ 30

+ 35a

+ 40

+ 50

White blood cells (×103/mm3)

14.2

10.6

3.4

5.4

3.7

18.9

5.5

Neutrophil count (× 103/mm3)

11.9

6.6

1.9

3.4

1.7

15.1

2.9

Hemoglobin (g/dL)

9.2

11.2

10.8

10.8

10.5

9.9

11.1

Platelet count (×103/mm3)

285

424

105

233

145

164

253

Erythrocyte sedimentation rate (mm/h)

75

68

43

55

63

50

36

C-reactive protein (mg/dL)

2.5

<  0.46

1.83

< 0.46

0.6

<  0.46

<  0.46

Aspartate aminotransferase (U/L)

61

40

350

111

113

35

31

Lactate dehydrogenase (U/L)

1673

1048

4960

1541

2122

1116

468

Triglycerides (mg/dL)

209

173

273

157

Fibrinogen (mg/dL)

356

418

234

297

424

312

267

Ferritin (ng/mL)

20,350

5065

49,700

17,580

28,634

12,340

201

  1. aStart of canakinumab administration